AAD 2026Abstract 75366
Ixekizumab Demonstrates Continued Improvements in Nail and Scalp Psoriasis through 52 Weeks
Final Results from the Psoriasis in Special Areas (PSoSA) Study
Jarell A, Lewitt GM, Serrao R, Costanzo A, Sabatino S, Walaszek-Naughton L, Edson-Heredia E, Bahl R, Merola JF
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1120 · Not in PubMed: details from Crossref